<ARTICLE> 5
<LEGEND>
This Schedule contains summary financial information extracted from the
Financial Statements of Progenics Pharmaceuticals, Inc. at June 30, 2000
and is qualified in its entirety by reference to such Financial
Statements.


                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      13,050,095
<SECURITIES>                                51,839,790
<RECEIVABLES>                                2,631,800
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            54,512,411
<PP&E>                                       3,693,687
<DEPRECIATION>                               2,441,201
<TOTAL-ASSETS>                              69,134,474
<CURRENT-LIABILITIES>                        1,990,569
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        15,800
<OTHER-SE>                                  66,706,192
<TOTAL-LIABILITY-AND-EQUITY>                69,134,474
<SALES>                                              0
<TOTAL-REVENUES>                             6,725,746
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             9,545,064
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              47,389
<INCOME-PRETAX>                             (2,866,707)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (2,866,707)
<EPS-BASIC>                                    (0.24)
<EPS-DILUTED>                                    (0.24)